Evidence Library

Showing 3 of 113 results.
Aaron Kesselheim, MD, JD, MPH •
Brigham & Women’s Hospital

Aaron Kesselheim, MD, JD, MPH, of the Division of Pharmacoepidemiology & Pharmacoeconomics at Brigham and Women’s Hospital discusses the effects on medical innovation of statutes that provide additional intellectual property rights or related incentives to pharmaceutical, medical device, and biotechnology developers in the U.S.

 
Kathleen Noonan, Ph.D. •
Children's Hospital of Philadelphia
Katherine Sell •
Dorothy Miller, J.D., M.P.H. •
Children's Hospital of Philadelphia
David Rubin •

Increasing concern about obesity and other nutrition-related health problems spurred governments to develop more robust and targeted approaches to foster healthier diet at a population level. Government routinely uses its regulatory power to alter activities and behaviors that influence public health, for example the New York City ban on the use of transfats in restaurants. Yet, in some scenarios, government may more effectively promote positive change through other means, including its purchasing or procurement authority.

 

Pages